Preclinical Studies and Drug Combination of Low-Cost Molecules for Chagas Disease

• Ngā kaituhi matua: Elena Aguilera (Author), Carina Sánchez (Author), María Eugenia Cruces (Author), Belén Dávila (Author), Lucía Minini (Author), Florencia Mosquillo (Author), Leticia Pérez-Díaz (Author), Elva Serna (Author), Susana Torres (Author), Alicia Schini (Author), Luis Sanabria (Author), Ninfa I. Vera de Bilbao (Author), Gloria Yaluff (Author), Flavio R. Zolessi (Author), Luis Fabian Ceilas (Author), Hugo Cerecetto (Author), Guzmán Alvarez (Author)
• Hōputu: Pukapuka
• I whakaputaina: MDPI AG, 2022-12-01T00:00:00Z.
• Ngā marau: article
• Urunga tuihono: Connect to this object online.

Chagas disease is caused by the protozoan <i>Trypanosoma cruzi</i> (<i>T. cruzi</i>). It remains the major parasitic disease in Latin America and is spreading worldwide, affecting over 10 million people. Hundreds of new compounds with trypanosomicidal action have been identif...